Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-09-07

Clinical Trial Update: Nebulized Magnesium Sulfate in Pediatric Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nebulized magnesium sulfate for pediatric asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebulized Magnesium Sulfate (magnesium sulfate)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Asthma | Phase 3 | Status: WITHDRAWN